Form 4: Amphastar Pharmaceuticals Executive Rong Zhou Reports Stock Transaction
SEC Form 4 Filing
Senior EVP Rong Zhou of Amphastar Pharmaceuticals reports disposition of shares to cover tax obligations related to vesting of restricted stock units.
Summary
- On March 6, 2024, Rong Zhou, Senior EVP of Production Center at Amphastar Pharmaceuticals, Inc., reported a transaction involving the company's common stock.
- A total of 1,390 shares were disposed of to cover tax liabilities related to the vesting of restricted stock units (RSUs) at a price of $46.31 per share.
- Following the transaction, Zhou directly owns 123,551 shares of common stock.
- Zhou also indirectly owns 99,668 shares through the Zhou Family Trust, where Zhou serves as a trustee, and 5,000 shares held by Zhou's spouse.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine stock transaction. It doesn't convey any particularly positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It doesn't necessarily reflect a change in the company's outlook or performance.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of stock transaction (disposal of shares). |
| 03/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.